SS
HRMY icon

SBI Securities’s Harmony Biosciences HRMY Stock Holding History

SBI Securities’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.97K Sell
219
-98
-31% -$3.09K ﹤0.01% 1950
2026
Q1 		$8.88K Buy
317
+111
+54% +$3.64K ﹤0.01% 1777
2025
Q4 		$7.71K Buy
206
+5
+2% +$164 ﹤0.01% 1838
2025
Q3 		$5.54K Buy
201
+69
+52% +$2.38K ﹤0.01% 1995
2025
Q2 		$4.17K Sell
132
-28
-18% -$901 ﹤0.01% 2069
2025
Q1 		$5.31K Buy
160
+60
+60% +$2.15K ﹤0.01% 1874
2024
Q4 		$3.44K Buy
+100
New +$3.44K ﹤0.01% 2069

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SBI Securities's HRMY Position: Q2 2026 in Review

SBI Securities reduced its Harmony Biosciences (HRMY) stake by 31% in Q2 2026, selling an estimated $3.09K and leaving 219 shares worth $7.97K. The position accounts for ﹤0.01% of the portfolio, ranked #1950.

SBI Securities first reported a position in HRMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.88K in Q1 2026. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • SBI Securities held 219 shares of Harmony Biosciences worth $7.97K as of Q2 2026.
  • SBI Securities sold 98 Harmony Biosciences shares in Q2 2026, an estimated $3.09K.
  • Harmony Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1950 holding.
  • SBI Securities first reported a position in Harmony Biosciences in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Harmony Biosciences position peaked at $8.88K in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.